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Ghrelin regulates homeostatic food intake, hedonic eating, and is a mediator in the stress response. In
addition, ghrelin has metabolic, cardiovascular, and anti-aging effects. This cross-sectional study exam-
ined associations between total plasma ghrelin, caloric intake based on 3 day diet diaries, hedonic eating
attitudes, stress-related and metabolic factors, and leukocyte telomere length in overweight (n = 25) and
obese women (n = 22). We hypothesized associations between total plasma ghrelin and eating behaviors,
stress, metabolic, cardiovascular, and cell aging factors among overweight women, but not among obese
women due to lower circulating ghrelin levels and/or central resistance to ghrelin. Conﬁrming previous
studies demonstrating lowered plasma ghrelin in obesity, ghrelin levels were lower in the obese compared
with overweight women. Among the overweight, ghrelin was positively correlatedwith caloric intake, giv-
ing in to cravings for highly palatable foods, and a ﬂatter diurnal cortisol slope across 3 days. These rela-
tionships were non-signiﬁcant among the obese group. Among overweight women, ghrelinwas negatively
correlated with insulin resistance, systolic blood pressure, and heart rate, and positively correlated with
telomere length. Among the obese subjects, plasma ghrelin concentrations were negatively correlated
with insulin resistance, but were not signiﬁcantly correlated with blood pressure, heart rate or telomere
length. Total plasma ghrelin and its associations with food intake, hedonic eating, and stress are decreased
in obesity, providing evidence consistent with the theory that central resistance to ghrelin develops in
obesity and ghrelin’s function in appetite regulation may have evolved to prevent starvation in food scar-
city rather than cope with modern food excess. Furthermore, ghrelin is associated with metabolic and car-
diovascular health, and may have anti-aging effects, but these effects may be attenuated in obesity.
 2014 Elsevier Ltd. All rights reserved.Introduction
Ghrelin, the only known appetite-stimulating hormone in
humans, is a 28 amino acid protein produced principally in the
stomach. Ghrelin and its receptor, growth hormone secretagogue
receptor (GHS-R), are found extensively throughout the body,
indicating widespread central and peripheral functions (Gnanapa-
van et al., 2002; Korbonits, Goldstone, Gueorguiev, & Grossman,
2004; Muccioli, Baragli, Granata, Papotti, & Ghigo, 2007). When
energy supply is low, ghrelin is secreted from gut mucosa and actscentrally by signaling to the hypothalamic arcuate nucleus and also
stimulates the vagal afferent nerves (Date & Kangawa, 2012) to in-
crease appetite and food intake. After food ingestion, plasma levels
decrease (Couce et al., 2006).
In addition to the regulation of homeostatic food intake ghrelin
appears to be involved in hedonic eating, and may be necessary for
the experience of food-induced reward (Diz-Chaves, 2011; King,
Isaacs, O’Farrell, & Abizaid, 2011; Kirsz & Zieba, 2011; Skibicka,
Hansson, Alvarez-Crespo, Friberg, & Dickson, 2011). There is evi-
dence that ghrelin increases preference for sweet taste (Disse
et al., 2010; Malik, McGlone, Bedrossian, & Dagher, 2008). More-
over, ghrelin was found to increase, rather than decrease, in re-
sponse to palatable food intake under conditions of satiety,
suggesting that ghrelin’s central signaling may drive hedonic food
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2013).
Furthermore, accumulating evidence suggests that ghrelin sig-
naling is important in the neurological response to stressors (Asak-
awa et al., 2001; Chuang et al., 2011; Raspopow, Abizaid,
Matheson, & Anisman, 2010; Rouach et al., 2007) and stress in-
creases ghrelin in humans (Harrold, Dovey, Blundell, & Halford,
2012; Lowe & Butryn, 2007). As stress induces eating and the moti-
vation to eat comfort foods (Adam & Epel, 2007; Dallman, 2010),
increased ghrelin may mediate the motivation to eat under stress.
Studies of diet-induced obese mice have demonstrated hypo-
thalamic resistance to ghrelin, in which ghrelin no longer stimu-
lates activation of neuropeptide Y (NPY) and agouti-related
peptide (AgRP) neurons, which trigger hunger (Briggs, Enriori,
Lemus, Cowley, & Andrews, 2010; Briggs et al., 2013; Finger, Dinan,
& Cryan, 2012). Diet-induced obesity in mice suppresses the neuro-
endocrine ghrelin system by decreasing mRNA of ghrelin and the
enzyme which converts ghrelin to its active acylated form (ghrelin
o-acyltransferase) in the stomach, expression of GHS-R in the
hypothalamus, and acylated and total plasma ghrelin (Briggs
et al., 2010). In humans, plasma ghrelin levels have been found
to be substantially lower among obese compared to lean adults
(Druce et al., 2005; McLaughlin, Abbasi, Lamendola, Frayo, &
Cummings, 2004; Ozkan et al., 2009; Tschop et al., 2001). These
ﬁndings have led to the speculation that obesity may induce
central ghrelin resistance in humans, and relationships between
ghrelin and eating behavior observed in lean adults may not apply
to obese populations (Andrews, 2011). However, little research has
examined the central resistance theory in obese humans. Further-
more, it is unclear whether evidence of central ghrelin resistance
would be observed in an overweight population, presumably
where there is also decreased plasma ghrelin, but perhaps not as
low as levels found in obese populations (Cummings, 2006; Sum-
ithran et al., 2011; Tschop et al., 2001).
In terms of other actions of ghrelin, ghrelin has been associated
with increased plasma glucose levels, decreased insulin and insulin
resistance, and with lower blood pressure and heart rate (Broglio
et al., 2001; Eizadi, Afsharmand, Behbudi, & Sohaily, 2011; Free-
man, Carmo, Adi, & da Silva, 2013; Garcia & Korbonits, 2006;
Okumura et al., 2002; Tong et al., 2010; Verhulst & Depoortere,
2012). Ghrelin may also have anti-aging effects as it reduces
inﬂammation (Dixit et al., 2004) and regulates growth hormone
secretion (Veldhuis & Keenan, 2012), which controls secretion of
insulin-like growth factor-1 (IGF-1). Lower levels of IGF-1 are re-
lated to shorter telomere length, which is a marker of cell aging
(Barbieri et al., 2009; Kaplan et al., 2009; Moverare-Skrtic et al.,
2009), and which has been linked to diabetes risk factors (Demissie
et al., 2006; Gardner et al., 2005) and earlier mortality (Blackburn,
Greider, & Szostak, 2006; Cawthon, Smith, O’Brien, Sivatchenko, &
Kerber, 2003; Epel et al., 2009; Fitzpatrick et al., 2011). Epidemio-
logical studies have shown that telomere length is moderately
correlated with chronological age (for a review, see Sanders &
Newman, 2013). Telomere length is thought to represent biological
aging of the cell in that the longer the telomere length, the greater
the cell’s ability to keep dividing, conversely, the shorter the
telomere length, the greater the cell’s replicative senescence
(Blackburn, 2000). As peripherally circulating ghrelin appears to
exert some beneﬁcial metabolic, cardiovascular and anti-aging
effects (Aoki et al., 2013; Garcia & Korbonits, 2006; Granado,
Priego, Martin, Villanua, & Lopez-Calderon, 2005), it is possible that
the lowered circulating levels found in obesity may negatively
impact ghrelin’s favorable physiological effects.
Indeed, there are many putative roles for ghrelin beyond
homeostatic appetite control, and research is needed to describe
and understand the multiplicity of ghrelin’s functions and any dif-
ferential functions of ghrelin among overweight and obese adults.In this preliminary cross-sectional analysis, we examined associa-
tions of ghrelin with caloric intake, hedonic eating, psychological
and physiological indicators of stress, metabolic and aging-related
factors among overweight and obese women. First, we hypothe-
sized that circulating plasma ghrelin levels would be lower among
obese compared to overweight women. Second, we hypothesized
that ghrelin may be positively related to food intake, hedonic eat-
ing, and stress among overweight women, but that such correla-
tions would be attenuated among obese women. We also aimed
to determine whether ghrelin’s previously established associations
with glucose and insulin levels, blood pressure, and heart rate
would be observed among the overweight and obese samples. Fi-
nally, we explored the relationship in both groups between ghrelin
and leukocyte telomere length, an association that has not yet been
examined in humans or animals to our knowledge.Methods
This study is a cross-sectional, secondary analysis of baseline
data collected from a randomized controlled pilot study of a mind-
fulness intervention to reduce stress eating (Daubenmier et al.,
2011). As previously reported in the parent study, overweight
and obese women were recruited from the San Francisco Bay Area
community using ﬂyers and local media. Exclusion criteria in-
cluded: weight over 300 lbs, diabetes, taking medication that could
affect weight loss, taking pain steroids or antipsychotic medication,
post-menopausal, history of bilateral oophorectomy, total hyster-
ectomy, polycystic ovary syndrome, active endocrine disorder,
pregnancy, less than 1 year postpartum or breastfeeding, current
eating disorder, alcohol addiction, drug addiction, positive urine
test for diabetes and opiate use, and English illiteracy. A total of
322 women were screened, and 47 women with Body Mass Index
(BMI) of 25–40 were enrolled into the study and completed 2 base-
line assessments by staff at the UCSF General Clinical Research
Center (GCRC) (Daubenmier et al., 2011). This study was performed
at the University of California, San Francisco (UCSF) with approval
from the institutional review board.Biological measures
At the ﬁrst baseline visit, a digital scale (Wheelchair Scale 6002,
Scale-Tronix, Carol Stream, IL) was used to measure weight in kg to
the nearest 0.10 kg and a standard stadiometer (Perspective Enter-
prises, Portage, Mich, USA) was used to measure height to the near-
est 1/8 in. to calculate BMI. Blood pressure and heart rate were also
measured (CritikonDinamap 1846SX Non Invasive Vital Signs Mon-
itor, GE Healthcare, Milwaukee, WI). To assess blood pressure, par-
ticipants rested for 5 min and three measurements were taken,
each 1 min apart. The three measurements were averaged to deter-
mine systolic and diastolic blood pressure values.
At the second baseline visit, nurses conﬁrmed with participants
that they completed a 12 h fast the night before. Morning blood
plasma samples were taken from an indwelling forearm catheter
for total plasma ghrelin levels, insulin, glucose, and telomere
length. Blood samples were drawn into tubes on ice containing
ethylenediaminetetraacetic acid (EDTA), an anticoagulant, and
kept on ice at all times. The tubes were centrifuged for 10 min at
3000 g at 4 C, transferred to aliquot vials, and frozen at 70 C
until assaying.
Total plasma ghrelin was measured without an extraction step
using a commercial RIA (Phoenix Peptide, Phoenix, AZ), as de-
scribed previously (Cummings, Clement, et al., 2002; Cummings
et al., 2001). Insulin was assayed with a radioimmunoassay kit
using an I125-Iodinated insulin tracer, anti-Human Insulin Speciﬁc
antibody, and human insulin standards from Linco Research, Inc.
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10.2% respectively. Glucose was measured enzymatically (glucose
oxidase) with an automated YSI 2300 Analyzer from YSI Life Sci-
ences (Yellow Spring, Ohio). Instrument precision is within 2%.
Insulin resistance was measured by homeostatic model assessment
(HOMA) from values obtained from plasma glucose and insulin as-
says (Wallace, Levy, & Matthews, 2004).
Salivary cortisol was measured by participants at home. Partic-
ipants were instructed on how to collect saliva samples by salivat-
ing into a straw in 2 ml ‘‘SaliCaps’’ tubes. They were instructed to
collect the ﬁrst sample before getting out of bed, and not to eat,
drink or brush their teeth or engage in vigorous activity between
the morning samples or for 20 min before the evening sample. Par-
ticipants collected saliva samples upon awakening, 30 min later,
and prior to bedtime. Samples for the cortisol awakening response
(CAR) were collected each day over 4 days, and samples for the cor-
tisol slope were collected each day over 3 days. The CAR was calcu-
lated by subtracting the 30-min post awakening sample from the
waking sample. Higher CARs are related to greater perceptions of
life stress (Chida & Steptoe, 2009). Cortisol slope was calculated
by subtracting the bedtime value from the morning value such that
higher values indicated steeper slopes. Flatter cortisol slopes are
associated with threatening, traumatic, and uncontrollable experi-
ences of stress (Schulkin, 2004). Values were averaged over the
days collected. Hormone analysis was performed at Dresden Lab
Service, overseen by Dr. Clemens Kirschbaum, at the Dresden Uni-
versity of Technology (Germany) using a commercial chemilumi-
nescence immunoassay (CLIA, IBL, Hamburg, Germany). Values
greater than 100 mg/dl were excluded as it is probable that these
values are physiologically abnormal, possibly due to blood contam-
ination or a medical or assay issue. They are also statistical outliers.
Mean telomere length was measured quantitatively in periphe-
ral blood nuclear cells. Telomere length was measured from DNA
by a quantitative polymerase chain reaction (PCR) assay that deter-
mines the relative ratio of telomere repeat copy number to single-
copy gene copy number (T/S ratio) in experimental samples as
compared with a reference DNA sample, as described previously
(Kiecolt-Glaser et al., 2013). All PCRs were carried out on a Roche
Lightcycler 480 real-time PCR machine with 384-tube capacity
(Roche Diagnostics Corporation, Indianapolis, IN) (Lin et al., 2010).
Self-report measures
Three day diet diaries
Participants were given paper forms to complete food diaries
over a 3 day period. As the participants consumed food, they were
instructed to record the types of food they ate and portion sizes.
The diaries were used to assess total daily caloric intake, and per-
centages of dietary calories from carbohydrates, fats, proteins, and
sugar. The Food Processor SQL software was used for nutritional
analysis.
Hedonic eating attitudes
Participants completed on-line questionnaires at home. Hedo-
nic eating attitudes were measured using the Food Craving Inven-
tory, which measures speciﬁc cravings and giving in to cravings for
foods high in fat, sugar, carbohydrates, and high fat fast-food over
the previous month. A craving was deﬁned as ‘‘an intense desire to
consume a particular food (or food type) that is difﬁcult to resist,’’
and the subscales ask participants to rate the frequency of cravings
on a 5-point Likert scale (1 = never, 2 = rarely, 3 = sometimes,
4 = often, and 5 = always/almost every day) (White, Whisenhunt,
Williamson, Greenway, & Netemeyer, 2002). Examples of foods in
the high fat category included fried ﬁsh, fried chicken, hot dog;
the sweet category included brownies, cookies, cakes; and the fast
food fats category included hamburgers, French fries, pizza. Toprovide a robust measure of highly palatable food cravings, two
composite scores were created. For the composite score of craving
highly palatable foods, we averaged the scores for high fat, sweet,
and fast-food fats. To measure ‘‘giving in’’ to cravings for highly
palatable foods, we averaged the scores for giving in to cravings
for high fat, sweet, and fast food fats. Cronbach’s alpha for these
composite measures of the Food Craving Inventory in this sample
was 0.86 for craving highly palatable foods, and 0.91 for giving in
to cravings.
Psychological stress
Psychological stress was measured using the 10-item version of
the Perceived Stress Scale. This measure utilizes a 5-point Likert
scale to evaluate the degree to which individuals consider their
lives to be stressful over the previous month (from 0 = never, to
4 = very often). Scores range from 0 to 40, with higher scores asso-
ciated with higher perceived stress (Cohen & Janicki-Deverts, 2012;
Cohen, Kamarck, & Mermelstein, 1983). Cronbach’s alpha for the
Perceived Stress Scale in this study was 0.84.
Emotional eating
Emotional eating is an individual’s trait behavior of eating in re-
sponse to negative emotions. Emotional eating was measured with
the Emotional Eating subscale of the Dutch Eating Behavior Ques-
tionnaire. The scale asks participants to rate their desire to eat in
response to clearly labeled and diffuse emotions, such as boredom
and anger using a 5-point Likert scale (ranging from 1 = never to
5 = very often). It has been widely used to assess emotional eating
in a variety of populations including obese women (Pinaquy,
Chabrol, Simon, Louvet, & Barbe, 2003; van Strien, Frijters, Bergers,
& Defares, 1986). Cronbach’s alpha for the Emotional Eating
subscale in this sample was 0.78.
Statistical analysis
Distributions and descriptive statistics of all variables were re-
viewed, including means and standard deviations for continuous
variables. Non-normal, skewed distributions were natural log
transformed. Student’s t-tests and chi-square tests were performed
to compare baseline characteristics between the overweight and
obese groups. The associations between ghrelin and the measured
variables were examined using Pearson correlations. One over-
weight participant, and three obese participants were taking
anti-hypertensive medications at the time of the study, and their
data were excluded from the correlations of plasma ghrelin with
blood pressure. All data were analyzed using Stata 12.0 (College
Station, TX, USA).Results
Sample characteristics
The sample characteristics are described in detail in the report
on the mindfulness intervention for stress eating (Daubenmier
et al., 2011). Out of 47 participants measured at baseline, 25 wo-
men were overweight, and 22 obese. As described previously, the
sample identiﬁed as 62% white, 15% Hispanic/Latino, 15% Asian/Pa-
ciﬁc Islander, and 9% other. The groups were similar in regards to
white/non-white status by BMI group (p = .34). Participants were
found to have higher mean levels of perceived stress, compared
to a representative U.S. population sample, and higher mean levels
of emotional eating compared to a representative Dutch sample
(Daubenmier et al., 2011).
The characteristics of the overweight and obese women are de-
scribed in Table 1. As expected, total fasting plasma ghrelin was
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J. Buss et al. / Appetite 76 (2014) 84–94 87lower in the obese compared to the overweight women (see Figs. 1
and 2 for scatterplots). There were no statistically signiﬁcant dif-
ferences in total daily calorie intake between the groups. However,
there were differences in percentage of caloric intake from fat and
carbohydrates between the two groups, with the obese women
consuming a greater percentage of calories from fat, and lower per-
centage from carbohydrates compared to the overweight women.
No statistically signiﬁcant differences between groups were found
in perceived stress, emotional eating, or hedonic eating attitudes.
Among the metabolic factors, the obese women had higher mean
insulin levels, and higher mean insulin resistance measured by
HOMA compared to the overweight women. The groups were sim-
ilar in regards to blood pressure and heart rate. There was no evi-
dence of a signiﬁcant difference in telomere length between the
groups, nor after controlling for age (p = .21).Fig. 1. Scatterplot of the relation between weight (kg) and plasma ghrelin.Correlations with plasma ghrelin and other variables
Correlations of total plasma ghrelin with food intake, hedonic
eating attitudes, stress related factors, metabolic factors, and telo-
mere length by weight status are shown in Table 2 and Figs. 3–9.
Among the overweight, ghrelin was positively associated with
average daily caloric intake and negatively correlated with per-
centage of calories from protein. Ghrelin appeared to be positively
related to percentage of calories from sugar, but this did not reach
statistical signiﬁcance (p = .058). These correlations were non-sig-
niﬁcant among the obese group. Ghrelin was not signiﬁcantly re-
lated to percentage of calories from fat or carbohydrate in either
group.
In terms of hedonic eating attitudes, ghrelin was positively
associated with giving into palatable foods in the overweight, but
not in the obese group. Ghrelin was not associated with cravings
for palatable foods in either group. Correlations of plasma ghrelin
with perceived stress, emotional eating, and the CAR were negligi-
ble in both groups. However, ghrelin was signiﬁcantly negativelyTable 1
Baseline characteristics of overweight and obese women.
n Overweight
Mean (SD)
Age (years) 25 41.76 (7.2)
Weight (kg) 25 75.17 (7.1)
Total plasma ghrelin (pg/ml) 25 409.27 (128
Food intake – Diet diaries
Average daily calories 22 2086.59 (54
% of calories from fat 22 32.21 (4.4)
% of calories from protein 22 17.78 (6.2)
% of calories from carbohydrates 22 50.41 (5.8)
% of calories from sugar 22 17.32 (6.2)
Hedonic eating attitudes
Craving palatable foods 24 51.67 (10.0
Giving into palatable foods 23 43.95 (15.3
Stress-related factors
Perceived stress 25 19.56 (6.6)
Emotional eating 24 3.29 (0.7)
Cortisol slope (nmol/L) 19 15.23 (6.6)
Cortisol awakening response (nmol/L) 23 7.06 (7.8)
Metabolic, cardiovascular, and cell aging factors
Glucose (mg/dl) 25 91.94 (5.5)
Insulin (lU/ml) 25 10.86 (5.7)
Insulin resistance (HOMA) 25 2.48 (1.3)
Systolic blood pressure (mmHg) 25 117.27 (14.
Diastolic blood pressure (mmHg) 25 72.21 (11.1
Heart rate (bpm) 25 73.36 (9.8)
Telomere length (T/S ratio) 25 1.11 (0.16)related to average cortisol slope in the overweight group, but the
relationship was non-signiﬁcant in the obese group.
Ghrelin was not related to glucose, but was signiﬁcantly nega-
tively correlated with insulin and insulin resistance in both the
overweight and obese groups. Excluding data from four partici-
pants who were taking anti-hypertensive medications, ghrelin
was negatively correlated with systolic blood pressure in both
groups, although the correlation did not reach statistical signiﬁ-
cance in the obese group (p = .06). There was some evidence to
indicate that ghrelin was negatively correlated with diastolic blood
pressure in the overweight group, although not statistically signif-
icant (p = .07), but we did not ﬁnd any evidence of a strong corre-
lation in the obese group.
Agewas not signiﬁcantly correlatedwith telomere length among
the overweight (r = .08, p = .70), although it was among the obese
group (r = .53, p < .05). Telomere length was signiﬁcantly posi-
tively correlatedwith ghrelin bivariately among the overweightwo-
men, but not among the obese group, nor after controlling for agen Obese p value
Mean (SD)
22 39.9 (7.5) 0.39
22 95.7 (12.6) <0.01
.9) 22 294.45 (116.2) <0.01
2.6) 20 2127.48 (412.0) 0.78
20 35.67 (6.4) 0.05
20 17.62 (4.0) 0.92
20 45.53 (7.2) 0.02
20 15.48 (4.3) 0.27
) 22 48.00 (12.6) 0.28
) 21 42.76 (15.7) 0.80
22 18.45 (5.0) 0.69
22 3.56 (0.8) 0.23
23 13.83 (4.1) 0.41
22 6.90 (8.1) 0.95
22 92.58 (9.7) 0.79
22 16.5 (9.6) 0.02
22 3.86 (2.6) 0.03
0) 22 123.3 (11.9) 0.12
) 22 71.70 (6.4) 0.84
22 74.14 (13.9) 0.83
20 1.08 (0.18) 0.28
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Fig. 2. Scatterplots of the relation between weight (kg) and plasma ghrelin by BMI group.
Table 2
Pearson correlations of ghrelin with eating, stress, and metabolic factors, and
telomere length by group.
Overweight Obese
n r n r
Three day diet diaries
Average daily calories 22 .51 20 .28
% of calories from fat 22 .14 20 .27
% of calories from protein 22 .43 20 .19
% of calories from carbohydrate 22 .25 20 .13
% of calories from sugar 22 .41^ 20 .08
Hedonic eating attitudes
Craving palatable foods 24 .24 22 .10
Giving into palatable foods 23 .44 21 .05
Stress-related factors
Perceived stress 25 .12 22 .05
Emotional eating 24 .25 22 .29
Cortisol awakening response (nmol/L) 23 .01 22 .11
Cortisol Slope (nmol/L) 19 .48 23 .27
Metabolic, cardiovascular, and cell aging factors
Glucose (mg/dl) 25 .16 22 .02
Insulin (lU/ml) 25 .57 22 .43
Insulin resistance (HOMA) (ln) 25 .66 22 .49
Systolic blood pressure (mmHg)a 24 .46 19 .44^
Diastolic blood pressure (mmHg)a 24 .38^ 19 .25
Heart rate (bpm) 25 .40 22 .00
Telomere length (T/S ratio) 25 .41 20 .28
a Excluding participants taking anti-hypertensive medication.
^ p < .10.
 p < .05.
 p < .01.
88 J. Buss et al. / Appetite 76 (2014) 84–94(partial r = .04, p = .88). In order to further understand the associ-
ation between ghrelin and telomere length among the overweight
group, we conducted exploratory analyses correlating telomere
lengthwith dietary (total daily caloric intake, percentages of dietary
calories from carbohydrates, fats, proteins, and sugar) and meta-
bolic (glucose, insulin, cortisol, insulin resistance, blood pressure
and heart rate) factors to identify potential dietary and biological
mediators. We found no signiﬁcant correlations with telomere
length except for percentage of calories from protein, which was
negatively related to telomere length (r = .59, p < .05).Discussion
Our results are consistent with those of previous studies show-
ing that plasma ghrelin decreases with weight gain, as the obesewomen had signiﬁcantly lower levels of ghrelin than the over-
weight women. Further research is needed to elucidate the rela-
tionship between body weight and circulating ghrelin to address
whether weight gain is a necessary factor for depleting circulating
ghrelin levels, or if it is a marker for other underlying metabolic
changes affecting total plasma ghrelin levels.
We found positive associations between ghrelin and eating
behaviors in the overweight, consistent with ﬁndings from studies
of normal weight adults and animals (Dickson et al., 2011; Disse
et al., 2010; Malik et al., 2008; Skibicka et al., 2011). Speciﬁcally,
we found that ghrelin was positively associated with daily caloric
intake. There was also some evidence in support of ghrelin’s role
in hedonic eating as overweight women reported giving in more
to eating palatable foods and ghrelin was also positively associated
with sugar intake, although the correlation did not quite reach sta-
tistical signiﬁcance (p = .058). These ﬁndings provide support for
the notion that ghrelin may promote hedonic eating in the over-
weight, as described in prior studies of lean adults and animals
(Chuang et al., 2011; Monteleone et al., 2012; Perello & Zigman,
2012; Schellekens, Dinan, & Cryan, 2013). However, this pattern
of results was not observed in the obese group. Correlations of
ghrelin with food intake and hedonic eating attitudes were weak
or tended to be negatively correlated.
One explanation for the differential pattern of ﬁndings among
the overweight and obese groups is that obesity produces resis-
tance to central signaling of ghrelin in the hypothalamus (Briggs
et al., 2010). It is not yet known whether resistance also occurs in
parts of the brain circuitry that signal food reward, such as the ven-
tral tegmental area. Of note, counter to the theory of central ghrelin
resistance, are the results of one study in which administration of
intravenous ghrelin to overweight and obese adults increased both
intake and palatability of food (Druce et al., 2005). Therefore, lack of
association of ghrelin with homeostatic and hedonic eating behav-
iors in obesity may be attributable to lowered circulating plasma
ghrelin levels or central resistance to ghrelin. Future work replicat-
ing many of the paradigms examining the role of ghrelin in hedonic
eating behaviors should be conducted among obese individuals.
Even though plasma ghrelin is reduced and may not impact eat-
ing behavior in obesity, ghrelin levels increase after weight loss
(Cummings, Weigle, et al., 2002; Hansen et al., 2002; Sumithran
et al., 2011). Researchers have suggested that the increase in circu-
lating ghrelin, particularly after calorie-restricted weight loss, may
make individuals more vulnerable to weight regain as the NPY and
AgRP neurons in the hypothalamus become re-sensitized to ghre-
lin’s signaling (Briggs et al., 2013). Further longitudinal study in
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Fig. 3. Scatterplots of the relation between average daily calories and plasma ghrelin by BMI group.
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Fig. 4. Scatterplots of the relation between giving into palatable food cravings and plasma ghrelin by BMI group.
J. Buss et al. / Appetite 76 (2014) 84–94 89humans is needed to observe if weight loss and rebound in plasma
ghrelin restores sensitivity to ghrelin signaling and if weight re-
gain occurs as a result of ghrelin re-sensitization. It has been sug-
gested that decreased ghrelin in obesity represents a physiological
adaptation to positive energy balance – rather than having a pur-
pose in diet-induced obesity, ghrelin’s key role is to maintain
homeostasis in times of negative energy balance. In other words,
ghrelin’s function in appetite regulation may have evolved to pre-
vent starvation in food scarcity rather than cope with food excess
(Andrews, 2011; Briggs & Andrews, 2011).
Reduced circulating ghrelin or central resistance in obesity may
impair ghrelin’s regulation of the HPA axis, as ghrelin stimulates
corticotropin-releasing hormone (CRH) secretion in mice (Asakawa
et al., 2001). Studies have also shown that ghrelin is responsive to
stress and may play a mediating role in stress-related eating (Chu-
ang et al., 2011; Rouach et al., 2007). In support, we found that a
ﬂatter diurnal cortisol slope, suggesting greater cortisol concentra-
tions in circulation throughout the day, was associated with higher
ghrelin levels among overweight women (Anders, 1982; Desir
et al., 1980). However, we did not ﬁnd this relationship in theobese group. We did not ﬁnd that ghrelin was related to self-
reported psychological stress or emotional eating in either weight
category. These null ﬁndings may be due to the restricted range of
these variables as our sample reported signiﬁcantly higher levels of
stress and emotional eating compared to representative samples.
In addition, as cortisol may be responsive to other factors aside
from psychological stress and we did not observe a signiﬁcant rela-
tionship between ghrelin and the cortisol awakening response
(Fries, Dettenborn, & Kirschbaum, 2009), future research could
examine associations with ghrelin in laboratory controlled studies
of stress to better determine the relation between ghrelin and
stress as a function of weight status.
While we found evidence supporting the view that ghrelin’s ac-
tions may be impaired in obesity, we found evidence that some of
ghrelin’s metabolic and cardiovascular-related actions may remain
intact while others may be impaired. Speciﬁcally, in both groups of
women we found that ghrelin was negatively related to insulin
resistance, as found in previous research (Amini et al., 2012;
Poykko et al., 2003). As plasma ghrelin decreases in the shift
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Fig. 5. Scatterplots of the relation between cortisol slope and plasma ghrelin by BMI group.
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Fig. 6. Scatterplots of the relation between insulin resistance (log transformed HOMA) and plasma ghrelin by BMI group.
90 J. Buss et al. / Appetite 76 (2014) 84–94towards obesity, there may be increases in insulin levels and
insulin resistance, which affect normal glucose homeostasis, and
may increase risk for metabolic disease. Ghrelin’s action in insulin
resistance may be due to the effect of higher plasma acylated ghre-
lin in obesity. Plasma ghrelin consists of acylated (A-GHR) and non-
acylated (NA-GHR). NA-GHR accounts for 80–90% of circulating
ghrelin; however, in obesity the ratio of A-GHR to NA-GHR may
be higher, and higher A-GHR is associated with insulin resistance
(Barazzoni et al., 2007; Paciﬁco et al., 2009). In addition, we found
ghrelin to be negatively correlated with systolic blood pressure
among the overweight and negatively correlated, although not sta-
tistically signiﬁcant, in the obese group. Ghrelin is associated with
lower blood pressure in healthy, normal weight adults (Garcia &
Korbonits, 2006; Okumura et al., 2002). The mechanism by which
ghrelin lowers blood pressure is not yet fully described; there is
evidence to suggest that it may be regulated through central mech-
anisms (Lin et al., 2004) and peripheral mechanisms by increasing
diuretic action through increased renal nitric-oxide production
(Aoki et al., 2013). Heart rate was also negatively correlated with
ghrelin among the overweight women, but not in the obese group.Central mechanisms may regulate heart rate as ghrelin modulates
baroreﬂex-regulation of sympathetic vasomotor tone (Krapalis
et al., 2012). It may be possible that as circulating ghrelin decreases
or central ghrelin resistance increases in obesity some beneﬁcial
cardiovascular effects may be reduced and this could potentially
explain the null association of ghrelin with heart rate and attenu-
ated associations between ghrelin and blood pressure among the
obese group.
Finally, growing research suggests that ghrelin may have anti-
aging effects (Dixit et al., 2004; Granado et al., 2005). We explored
the relationship between ghrelin and leukocyte telomere length, a
marker of aging (Sanders & Newman, 2013). Longer telomeres have
been related to less inﬂammation and higher levels of IGF-1, which,
in part, are regulated by ghrelin (Barbieri et al., 2009; Dixit et al.,
2004; Kaplan et al., 2009; Moverare-Skrtic et al., 2009). We found
that ghrelin was positively associated with telomere length among
the overweight but not among the obese women. We did not as-
sess inﬂammatory markers or IGF-1 in this study so could not
examine these factors as potential mechanisms. However, we
found that ghrelin was negatively associated with daily percentage
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Fig. 7. Scatterplots of the relation between systolic blood pressure and plasma ghrelin by BMI group. Excluding participants taking anti-hypertensive medication.
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Fig. 8. Scatterplots of the relation between heart rate and plasma ghrelin by BMI group.
J. Buss et al. / Appetite 76 (2014) 84–94 91of calories from protein, and, in exploratory analyses, less dietary
protein intake was associated with greater telomere length among
the overweight women. Animal studies have shown that decreased
protein intake is associated with longer telomeres (O’Callaghan
et al., 2012; Tanrikulu-Kucuk & Ademoglu, 2012). Therefore, lower
dietary protein intake might have a beneﬁcial effect on telomere
length. Overweight women with higher plasma ghrelin levels
may eat foods higher in carbohydrates and fats, and as percent cal-
ories from macronutrients are dependent on one another, protein
consumption may decrease. Alternatively, there is evidence to sug-
gest that protein intake suppresses ghrelin levels, at least acutely
(Blom et al., 2006; Bowen, Noakes, & Clifton, 2006; Brennan
et al., 2012; Erdmann, Topsch, Lippl, Gussmann, & Schusdziarra,
2004; Foster-Schubert et al., 2008; Moran et al., 2005; Tannous
dit El Khoury, Obeid, Azar, & Hwalla, 2006). Further research is
needed to elucidate the pathways by which ghrelin may affect cel-
lular aging mechanisms, such as telomere length, and whether
these pathways are attenuated in obesity.
Limitations
Our analysis is cross-sectional and therefore we are unable to
determine causality. The study sample did not include men,therefore we do not know whether there are gender differences
in the associations that we found. Our results should also be con-
sidered preliminary due to a small sample size. Further research
is needed to examine and replicate the associations we described,
in particular, by including normal weight adults. We measured
total plasma ghrelin, but circulating ghrelin is found as acylated
and non-acylated, both with different roles in promoting appetite
and feeding (Adams, Greenway, & Brantley, 2011). Although total
plasma ghrelin is lower in obesity, the ratio of acylated to non-
acylated may increase in obesity (Paciﬁco et al., 2009). Future
work should examine both acylated and non-acylated ghrelin in
obesity.
Central ghrelin sensitivity may be affected by circulating leptin
concentrations (Hewson, Tung, Connell, Tookman, & Dickson,
2002). Moreover, as ghrelin promotes feeding and leptin sup-
presses feeding, there is evidence to suggest that plasma ghrelin
levels are negatively associated with plasma leptin levels and
their actions on hypothalamic neurons may be oppositional, at
least in normal weight adults and animals (Lockie & Andrews,
2013). However, diet-induced obese individuals are resistant to
the effects of leptin (Mantzoros et al., 2011). Further research is
needed to examine the relation between ghrelin and leptin in
obesity.
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Fig. 9. Scatterplots of the relation between telomere length and plasma ghrelin by BMI group.
92 J. Buss et al. / Appetite 76 (2014) 84–94Some studies (Al-Massadi et al., 2010; Kellokoski et al., 2005;
Matsubara et al., 2004; Shibata et al., 2004), but not all (Dafopou-
los, Sourlas, Kallitsaris, Pournaras, & Messinis, 2009; Gualillo et al.,
2001) have found associations with ghrelin levels and ovarian
hormones, so it is possible that the ﬁndings in this study are
affected by participants’ menstrual cycle or use of oral contracep-
tion. Postmenopausal, and pregnant and breastfeeding women
were excluded from this study, as were those with a history of
polycystic ovary syndrome, oophorectomy, and hysterectomy.
Hedonic eating, diet diaries and psychological stress were
measured using self-report instruments. Self-report data may
introduce error as individuals may not recall information with
accuracy, give socially desirable responses, or choose not to re-
spond. Hedonic eating and psychological stress measures were col-
lected on-line when participants were at home. We did not record
or control for the time of day or other situational factors that may
have inﬂuenced participant self-reports.Conclusion
Our results indicate a complex picture of the potential health
impact of circulating ghrelin concentrations in overweight and
obesity. Ghrelin in overweight people may contribute to hedonic
eating and eventual weight gain. However, lowered circulating
ghrelin and/or central resistance to ghrelin signaling in obesity
may reduce the impact of ghrelin on homeostatic energy regula-
tion and hedonic eating. Ghrelin may have beneﬁcial metabolic,
cardiovascular and anti-aging effects and these effects may be
attenuated in obesity. Future work is needed to examine the role
of ghrelin in obesity, especially as regards eating behavior.Funding
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